Cancer research firm under threat

CANCER drug research firm EiRx Therapeutics said it will cease trading next week unless it completes a fundraising.

The company, which is based in the Cork Airport Business Park and quoted on London’s Alternative Investment Market, said in November that it would require fresh funding by January if it was to continue trading.

In a statement yesterday, it said it has managed its resources such that it must undertake a fundraising by Friday, February 15, if it is to continue trading beyond that date.